Insulet Stock Down 21.9% on Weaker 2026 Revenue Outlook

SentiSense · Published · Updated

Insulet reported disappointing 2026 revenue outlook, citing weaker Type 2 retention. Analysts have slashed their forecasts and downgraded the company....

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis